Insights into the Notch signaling pathway in degenerative musculoskeletal disorders: Mechanisms and perspectives - 04/12/23
, Ali Mobasheri e, f, g, h, i, j, ⁎
, Yusheng Li a, b, ⁎ 
Abstract |
Degenerative musculoskeletal disorders are a group of age-related diseases of the locomotive system that severely affects the patient's ability to work and cause adverse sequalae such as fractures and even death. The incidence and prevalence of degenerative musculoskeletal disorders is rising owing to the aging of the world’s population. The Notch signaling pathway, which is expressed in almost all organ systems, extensively regulates cell proliferation and differentiation as well as cellular fate. Notch signaling shows increased activity in degenerative musculoskeletal disorders and retards the progression of degeneration to some extent. The review focuses on four major degenerative musculoskeletal disorders (osteoarthritis, intervertebral disc degeneration, osteoporosis, and sarcopenia) and summarizes the pathophysiological functions of Notch signaling in these disorders, especially its role in stem/progenitor cells in each disorder. Finally, a conclusion will be presented to explore the research and application of the perspectives on Notch signaling in degenerative musculoskeletal disorders.
Le texte complet de cet article est disponible en PDF.Highlights |
• | The Notch signaling pathway has a dual role in the progression of degenerative musculoskeletal disorders, which are progressively becoming a great social burden with the accelerating aging worldwide. |
• | The primary physiological role of Notch signaling engenders the hypothesis that the senescent cells in these degenerative disorders are still “saving themselves” through reactivation of Notch signaling. |
• | Many approaches or pathways can affect the expression of Notch signaling to maintain cell pool homeostasis, and conversely, regulating Notch signaling can treat or even reverse the development of degenerative musculoskeletal disorders. |
Keywords : Notch signaling pathway, Degenerative musculoskeletal disorders, Osteoarthritis, Osteoporosis, Sarcopenia, Intervertebral disc degeneration, Stem/progenitor cells
Plan
Vol 169
Article 115884- décembre 2023 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
